Relationship between ADP-induced platelet-fibrin clot strength and anti-platelet responsiveness in ticagrelor treated ACS patients

BACKGROUND: Ticagrelor provides enhanced antiplatelet efficacy but increased risk of bleeding and dyspnea. This study aimed to display the relationship between ADP-induced platelet-fibrin clot strength (MA(ADP)) and clinical outcomes in acute coronary syndrome (ACS) patients treated by ticagrelor. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Dan-Dan, Wang, Xu-Yun, Xi, Shao-Zhi, Liu, Jia, Qin, Liu-An, Jing, Jing, Yin, Tong, Chen, Yun-Dai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Science Press 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4921539/
https://www.ncbi.nlm.nih.gov/pubmed/27403136
http://dx.doi.org/10.11909/j.issn.1671-5411.2016.04.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4921539/
https://www.ncbi.nlm.nih.gov/pubmed/27403136
http://dx.doi.org/10.11909/j.issn.1671-5411.2016.04.012

Ejemplares similares